Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 19.5B | 18.4B | 16.3B | 18.6B |
Cost of revenue | 12.5B | 12.3B | 10.2B | 11.6B |
Gross profit | 7.0B | 6.1B | 6.1B | 7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 3.3B | 2.7B | 3.1B | 2.8B |
Operating income | 1.5B | 1.2B | 880M | 2.0B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 640M | 850M | 620M | 640M |
Other income expense | — | — | — | — |
Pretax income | 880M | 400M | 340M | 1.5B |
Tax provision | -70M | -60M | -180M | 80M |
Net income | 960M | 460M | 520M | 1.4B |
Basic EPS | — | 1.3 | 1.4 | 3.8 |
Diluted EPS | — | 1.3 | 1.4 | 3.8 |
Basic average shares | — | 362.2M | 361.1M | 363.4M |
Diluted average shares | — | 362.2M | 361.1M | 363.4M |
EBITDA | 2.7B | 2.4B | 2.0B | 3.1B |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |